These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18465802)

  • 1. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Tez M; Zulfikaroglu B
    Cancer; 2008 Jun; 112(12):2820-1; author reply 2821. PubMed ID: 18465802
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
    Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
    Schumacher G; Gebauer B
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
    [No Abstract]   [Full Text] [Related]  

  • 4. Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea.
    Giannini EG; Savarino V; Risso D; Di Nolfo MA; Del Poggio P; Benvegnù L; Farinati F; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2010 Jul; 30(6):923-4; author reply 924-5. PubMed ID: 20214738
    [No Abstract]   [Full Text] [Related]  

  • 5. Transarterial chemoembolization for hepatocellular carcinoma.
    Lau WY; Yu SC; Lai EC; Leung TW
    J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic prediction and treatment strategy in hepatocellular carcinoma.
    Bruix J; Llovet JM
    Hepatology; 2002 Mar; 35(3):519-24. PubMed ID: 11870363
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma (Br J Surg 2003; 90: 325-331).
    Sen G; Rai R; Manas DM
    Br J Surg; 2003 Aug; 90(8):1022. PubMed ID: 12905563
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    Flohr F; Harder J; Seufert J; Blum HE; Spangenberg HC
    Hepatology; 2008 Jun; 47(6):2144. PubMed ID: 18459123
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization of hepatic malignancy.
    Gonsalves CF; Brown DB
    Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.
    Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C
    Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatocellular carcinoma.
    Del Pozo AC; López P
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of hepatocellular carcinoma. New developments].
    Kuiken SD; van Delden OM; Richel DJ; Jansen PL
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):668-72. PubMed ID: 19425326
    [No Abstract]   [Full Text] [Related]  

  • 15. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.
    Reichman TW; Anthony T; Millis JM; Testa G
    Dig Liver Dis; 2009 Feb; 41(2):175-6. PubMed ID: 18849205
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.
    Morante A; Romano M; Cuomo A; de Sio I; Cozzolino A; Mucherino C; Salerno R; Blanco Cdel V; Romano M
    Gastrointest Endosc; 2006 Apr; 63(4):718-20. PubMed ID: 16564887
    [No Abstract]   [Full Text] [Related]  

  • 18. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
    Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F
    Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advanced hepatocellular carcinoma].
    Okazaki M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():417-21. PubMed ID: 11761984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.